PPT Slide

Systemic Inactivation of Alfimeprase by Alpha-2 Macroglobulin Allows for Potentially Fewer Side-Effects

ALFIMEPRASE

BLOOD VESSEL

DEGRADES

FIBRIN

DISSOLVES

CLOT

ALFIMEPRASERAPIDLY INACTIVATEDIN SYSTEMIC CIRCULATION

Novel Acting Thrombolytic